We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-14.83%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$5.16B
AUM Growth
-$1.15B
Cap. Flow
+$52.2M
Cap. Flow %
1.01%
Top 10 Hldgs %
40.75%
Holding
232
New
16
Increased
80
Reduced
52
Closed
17

Top Buys

Rank Stock Value
1
BDTX icon
Black Diamond Therapeutics
BDTX
+$40.5M
2
FATE icon
Fate Therapeutics
FATE
+$37.4M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$29.7M
4
ESPR
Esperion Therapeutics
ESPR
+$27.1M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$25.4M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$63.8M
2
BMY icon
Bristol-Myers Squibb
BMY
+$54M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$26.7M
4
MRNA icon
Moderna
MRNA
+$22.7M
5
ALGN icon
Align Technology
ALGN
+$18.1M

Sector Composition

Rank Sector Weight
1 Healthcare 95.76%
2 Technology 0.56%
3 Industrials 0.54%
4 Communication Services 0.17%
5 Financials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPGI icon
176
S&P Global
SPGI
$133B
$417K 0.01%
1,700
– –
CSGP icon
177
CoStar Group
CSGP
$12.1B
$411K 0.01%
+7,000
New +$456K
SQM icon
178
Sociedad Química y Minera de Chile
SQM
$19.3B
$410K 0.01%
18,200
– –
IBKR icon
179
Interactive Brokers
IBKR
$40.8B
$406K 0.01%
37,600
– –
CL icon
180
Colgate-Palmolive
CL
$73.6B
$405K 0.01%
6,100
– –
MKC icon
181
McCormick & Company Non-Voting
MKC
$14B
$395K 0.01%
5,600
– –
HTHT icon
182
Huazhu Hotels Group
HTHT
$12.8B
$388K 0.01%
13,500
– –
ICE icon
183
Intercontinental Exchange
ICE
$80.1B
$388K 0.01%
4,800
– –
IPGP icon
184
IPG Photonics
IPGP
$4.16B
$386K 0.01%
3,500
– –
VRSN icon
185
VeriSign
VRSN
$25.3B
$378K 0.01%
2,100
– –
TRMB icon
186
Trimble
TRMB
$12.4B
$372K 0.01%
11,700
– –
MKL icon
187
Markel Group
MKL
$24.8B
$371K 0.01%
400
– –
ADI icon
188
Analog Devices
ADI
$181B
$368K 0.01%
4,100
– –
RVTY icon
189
Revvity
RVTY
$11.9B
$361K 0.01%
4,800
– –
EL icon
190
Estee Lauder
EL
$30.3B
$358K 0.01%
2,248
– –
MTCH icon
191
Match Group
MTCH
$9.11B
$350K 0.01%
+5,300
New +$390K
VRSK icon
192
Verisk Analytics
VRSK
$26.4B
$347K 0.01%
2,489
– –
PAYX icon
193
Paychex
PAYX
$41B
$340K 0.01%
5,400
– –
LABU icon
194
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$579M
$338K 0.01%
+750
New +$682K
TRU icon
195
TransUnion
TRU
$15.2B
$337K 0.01%
5,096
– –
SCI icon
196
Service Corp International
SCI
$10.8B
$332K 0.01%
8,500
– –
XLNX
197
DELISTED
Xilinx Inc
XLNX
$327K 0.01%
4,200
– –
BR icon
198
Broadridge
BR
$17.4B
$322K 0.01%
3,400
– –
ALV icon
199
Autoliv
ALV
$8.58B
$313K 0.01%
6,800
– –
MTB icon
200
M&T Bank
MTB
$36.2B
$310K 0.01%
3,000
– –
6 7
8
9 10

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q1 2020 Portfolio in Review

As of Q1 2020, Bellevue Group held 232 positions worth $5.16B, down 18% from $6.31B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Bellevue Group's Q1 2020 filing shows 16 new, 80 increased, 52 reduced and 17 closed positions. Its largest new stake was Black Diamond Therapeutics: 1,330,000 shares worth $33.2M. The largest sale was Teladoc Health, an estimated $63.8M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Technology and Industrials.

  • Bellevue Group's largest Q1 2020 buy was Black Diamond Therapeutics: 1,330,000 shares worth $33.2M.
  • Bellevue Group added most to Fate Therapeutics in Q1 2020, an estimated $37.4M increase.
  • Bellevue Group's biggest Q1 2020 reduction was Teladoc Health, cutting an estimated $63.8M.
  • Bellevue Group fully exited Wright Medical Group Inc in Q1 2020, selling an estimated $17.1M.
  • Bellevue Group's ten largest holdings make up 41% of its $5.16B portfolio in Q1 2020.
  • Bellevue Group opened 16 new positions and closed 17 in Q1 2020.
  • Bellevue Group's portfolio value fell 18% quarter-over-quarter to $5.16B.

Based on Bellevue Group's 13F filing for Q1 2020, filed 14 May 2020.